Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye diseases
Biotech
Ocugen’s CEO wants to bring gene therapy to the masses
Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri, Ph.D., said, meaning they miss out on broader commercial success.
Darren Incorvaia
Apr 16, 2026 9:00am
Scientists turn pig semen extract into cancer-killing eye drops
Mar 27, 2026 2:39pm
UK biotech eyes $1B deal to deliver eye gene therapy at doctor
Jan 6, 2026 6:25am
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
Fatty acid eye injections restore vision in old mice
Sep 26, 2025 2:10pm
Alcon to buy LumiThera’s light-based therapy for dry AMD
Jul 8, 2025 10:30am